BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21990651)

  • 41. New concepts in heparin-induced thrombocytopenia: diagnosis and management.
    Spinler SA
    J Thromb Thrombolysis; 2006 Feb; 21(1):17-21. PubMed ID: 16475037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
    Badger NO
    J Pharm Pract; 2010 Jun; 23(3):235-8. PubMed ID: 21507819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of heparin-induced thrombocytopenia.
    Jaax ME; Greinacher A
    Expert Opin Pharmacother; 2012 May; 13(7):987-1006. PubMed ID: 22475438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacotherapy of heparin- induced thrombocytopenia.
    Dager WE; White RH
    Expert Opin Pharmacother; 2003 Jun; 4(6):919-40. PubMed ID: 12783589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparin-induced thrombocytopenia: pathophysiology and clinical concerns.
    Greinacher A
    Baillieres Clin Haematol; 1998 Jun; 11(2):461-74. PubMed ID: 10097820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacotherapy of heparin-induced thrombocytopenia: therapeutic options and challenges in the clinical practices.
    Al-Eidan FA
    J Vasc Nurs; 2015 Mar; 33(1):10-20. PubMed ID: 25700733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and cost.
    Smythe MA; Koerber JM; Mehta TP; Forsyth LL; Conger E; Corbets LR; Mattson JC
    Thromb Haemost; 2012 Nov; 108(5):992-8. PubMed ID: 22955669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin-induced thrombocytopenia: a practical review.
    Hong MS; Amanullah AM
    Rev Cardiovasc Med; 2010; 11(1):13-25. PubMed ID: 20495512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia.
    Pon TK; Mahajan A; Rosenberg A; Amin A; Shah D; Jenkins I; Gupta V; Hofmann H; Bejjani A; White R
    J Thromb Thrombolysis; 2018 May; 45(4):536-542. PubMed ID: 29574610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Mahaffey KW
    Curr Cardiol Rep; 2001 Sep; 3(5):362-70. PubMed ID: 11504572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis].
    Esposito P; Libetta C; Borettaz I; Barone M; Canevari M; Martinelli C; Montagna F; Romeo S; Margiotta E; Calatroni M; La Porta E; Dal Canton A
    G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heparin-induced thrombocytopenia.
    Krzych ŁJ; Nowacka E; Knapik P
    Anaesthesiol Intensive Ther; 2015; 47(1):63-76. PubMed ID: 25751293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laboratory methods and management of patients with heparin-induced thrombocytopenia.
    Prechel M; Jeske WP; Walenga JM
    Methods Mol Biol; 2010; 663():133-56. PubMed ID: 20617416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiology for the primary care provider: heparin-induced thrombocytopenia.
    Benton RE; Gersh BJ
    South Med J; 1998 Feb; 91(2):133-7. PubMed ID: 9496863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Heparin-induced thrombocytopenia (HIT). Importance for anesthesia and intensive care].
    Kleinschmidt S; Seyfert UT
    Anaesthesist; 1999 Nov; 48(11):771-85. PubMed ID: 10631436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case studies in heparin-induced thrombocytopenia.
    Andreescu AC; Cushman M
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():71-76. PubMed ID: 11155197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management.
    Hogan M; Berger JS
    Vasc Med; 2020 Apr; 25(2):160-173. PubMed ID: 32195628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis and management of heparin-induced thrombocytopenia.
    de Maistre E; Gruel Y; Lasne D
    Can J Anaesth; 2006 Jun; 53(6 Suppl):S123-34. PubMed ID: 16766786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin-induced thrombocytopenia in the ICU: an overview.
    Sakr Y
    Crit Care; 2011; 15(2):211. PubMed ID: 21457505
    [No Abstract]   [Full Text] [Related]  

  • 60. [Heparin-induced thrombocytopenia].
    Koide M; Matsuo T
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):307-10. PubMed ID: 9833497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.